News | March 09, 2023
Evonik opens new facility for pharmaceutical lipids in Germany
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
This order is subject to initial advance payment as per the agreed terms of the contract
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
Subscribe To Our Newsletter & Stay Updated
